Carly Kenselaar

Stock Analyst at Citigroup

(3.00)

# 1,318

Out of 4,854 analysts

6

Total ratings

80%

Success rate

47.86%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$31 → $35	$15.32	+128.53%	5	Feb 24, 2025
	KRYS Krystal Biotech	Initiates: Buy	$160	$136.94	+16.84%	1	Oct 12, 2023

Travere Therapeutics

Feb 24, 2025

Maintains: Buy

Price Target: $31 → $35

Current: $15.32

Upside: +128.53%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $136.94

Upside: +16.84%